8. STOCKHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2018

Stockholders Equity And Sharebased Compensation Tables Abstract

Stock option activity

			Weighted Average
	Options on				Remaining		Aggregate
	Common		Exercise		Contractual		Intrinsic
	Shares		Price		Term		Value
Outstanding January 1, 2018		-		-		-	$	-
Granted		2,067,500	$	1.68		4.44		-
Exercised		-		-		-		-
Forfeited, cancelled, expired		-		-		-		-
Outstanding December 31, 2018		2,067,500	$	1.68		4.44	$	3,063,375
Vested and exercisable at December 31, 2018		225,000	$	1.50		4.39	$	371,250

Stock-based compensation

	Year
	Ended December 31,
	2018		2017
Selling, general and administrative	$	417,151	$	-
Research and development		95,837		-
Total stock-based expense	$	512,988	$	-

Assumptions used to compute the fair value of options granted

	Year
	Ended
	December 31,
	2018
Expected stock price volatility	47% to 49%
Risk-free interest rate	2.67% to 2.99%
Forfeiture rate		0	%
Expected dividend yield		0	%
Expected life of options - years		2.75 - 5.00
Weighted-average fair value of options granted	$	0.72

Stock options outstanding

				Weighted
				Average		Weighted				Weighted
				Remaining		Average				Average
Range of		Number		Contractual		Exercise		Number		Exercise
Exercise Prices		Outstanding		Life		Price		Exercisable		Price
$	1.50		1,847,500		4.39	$	1.50		225,000	$	1.50
$	3.00 - $3.61		220,000		4.82	$	3.23		-		-

Warrants

	Number of		Exercise Price
Description	Common Shares		Per Share		Expiration Date
Purchase Warrants (1)		4,561,074	$	5.00	October 30, 2020
Agent Warrants		456,107	$	3.00	October 30, 2020